Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (301)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.89
Total Value
$48.95K
Shares Held After
3,042,000
% of Holdings
0.3%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
5,000
Price
$5.19
Total Value
$25.95K
Shares Held After
3,032,000
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$5.61
Total Value
$56.05K
Shares Held After
3,027,000
% of Holdings
0.3%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
40,000
Price
$2.03
Total Value
$81.20K
Shares Held After
203,797
% of Holdings
19.6%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
5,000
Price
$6.32
Total Value
$31.60K
Shares Held After
3,017,000
% of Holdings
0.2%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
123,000
Price
$2.05
Total Value
$252.15K
Shares Held After
163,797
% of Holdings
75.1%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.03
Total Value
$50.75K
Shares Held After
160,679
% of Holdings
15.6%
Altimmune, Inc. (ALT)
GILL JOHN — Director
Shares
9,200
Price
$3.41
Total Value
$31.35K
Shares Held After
21,700
% of Holdings
42.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
20,000
Price
$6.09
Total Value
$121.80K
Shares Held After
3,012,000
% of Holdings
0.7%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%
Altimmune, Inc. (ALT)
WEAVER GREGORY L — Chief Financial Officer
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
Processa Pharmaceuticals, Inc. (PCSA)
Neal James R — Director
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
520
Price
$10.60
Total Value
$5.51K
Shares Held After
1,538,296
% of Holdings
0.0%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,854
Price
$2.54
Total Value
$4.70K
Shares Held After
3,110
% of Holdings
59.6%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,136
Price
$2.54
Total Value
$5.41K
Shares Held After
3,649
% of Holdings
58.5%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,603
Price
$2.54
Total Value
$4.06K
Shares Held After
3,356
% of Holdings
47.8%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,810
Price
$2.54
Total Value
$4.59K
Shares Held After
10,562
% of Holdings
17.1%
Processa Pharmaceuticals, Inc. (PCSA)
Pannu Geraldine — Director
Shares
2,072
Price
$2.54
Total Value
$5.25K
Shares Held After
2,188
% of Holdings
94.7%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
Processa Pharmaceuticals, Inc. (PCSA)
Baluch Khoso — Director
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%
Connect Biopharma Holdings Ltd (CNTB)
Huang James — Director
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
Zenas BioPharma, Inc. (ZBIO)
Fairmount Funds Management LLC — Director
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%
CURIS INC (CRIS)
KAITIN KENNETH I — Director
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
Rezolute, Inc. (RZLT)
Evans Daron — CFO
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%
Mineralys Therapeutics, Inc. (MLYS)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
971,091
Price
$6.50
Total Value
$6.31M
Shares Held After
26,975,505
% of Holdings
3.6%
Mineralys Therapeutics, Inc. (MLYS)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
310,700
Price
$23.67
Total Value
$7.35M
Shares Held After
5,767,221
% of Holdings
5.4%
Immunome Inc. (IMNM)
SIEGALL CLAY B — Director
Shares
25,450
Price
$19.67
Total Value
$500.60K
Shares Held After
690,704
% of Holdings
3.7%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
2,495,623
Price
$6.43
Total Value
$16.05M
Shares Held After
26,004,414
% of Holdings
9.6%
LENZ Therapeutics, Inc. (LENZ)
Chevallard Daniel R. — Chief Financial Officer
Shares
7,500
Price
$8.57
Total Value
$64.28K
Shares Held After
12,886
% of Holdings
58.2%
LENZ Therapeutics, Inc. (LENZ)
George Jeffrey P. — Director
Shares
5,592
Price
$8.92
Total Value
$49.89K
Shares Held After
5,592
% of Holdings
100.0%
LENZ Therapeutics, Inc. (LENZ)
Schimmelpennink Evert B. — Director
Shares
28,089
Price
$8.95
Total Value
$251.41K
Shares Held After
77,289
% of Holdings
36.3%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
351,224
Price
$6.38
Total Value
$2.24M
Shares Held After
23,508,791
% of Holdings
1.5%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
4,954,558
Price
$6.06
Total Value
$30.02M
Shares Held After
23,157,567
% of Holdings
21.4%
Xilio Therapeutics, Inc. (XLO)
Shannon James Samuel — Director
Shares
5,000
Price
$8.79
Total Value
$43.95K
Shares Held After
10,000
% of Holdings
50.0%
iBio, Inc. (IBIO)
Banjak Marc — Chief Legal Officer
Shares
1,434
Price
$1.76
Total Value
$2.52K
Shares Held After
25,000
% of Holdings
5.7%
Showing 1–50 of 301 transactions (page 1 of 7)